Medicus Pharma Ltd.
MDCX
$2.17
-$0.05-2.25%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.18M | -5.10M | -2.27M | -2.96M | -3.63M |
| Total Depreciation and Amortization | -- | -- | -78.40K | 26.30K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 453.30K | 135.80K | 188.50K | 9.00K | 695.40K |
| Change in Net Operating Assets | 254.00K | 1.03M | -1.10M | -144.10K | 160.70K |
| Cash from Operations | -5.47M | -3.94M | -3.27M | -3.07M | -2.78M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 4.50M | -- | 0.00 | 0.00 | 5.17M |
| Total Debt Repaid | -- | -- | 35.00K | -35.00K | -- |
| Issuance of Common Stock | 6.98M | 3.78M | 2.05M | 0.00 | 5.47M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -327.40K | -25.00K | 40.60K | 0.00 | -- |
| Cash from Financing | 11.16M | 3.76M | 2.13M | -35.00K | 10.64M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.69M | -181.90K | -1.14M | -3.10M | 7.87M |